Development of novel sustained release bioadhesive vaginal tablets of povidone iodine

Drug Development and Industrial Pharmacy

Volumn 33, Issue 12, 2007, Pages 1340-1349

  Garg, Sanjay ^a   Jambu, Lavit ^b   Vermani, Kavita ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^c Adamas Pharmaceuticals Inc   (United States)

Author keywords

Bioadhesive; Iodophores; Sustained release; Vaginal delivery

Indexed keywords

CHITOSAN GLUTAMATE; CROSPOVIDONE; EXCIPIENT; HYDROXPROPYL CELLULOSE; IODOPHOR; MAGNESIUM STEARATE; PIVIPOL; POVIDONE; POVIDONE IODINE; UNCLASSIFIED DRUG; VIRAC; WOKADINE; XANTHAN;

ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG MARKETING; DRUG RELEASE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHYSICAL CHEMISTRY; VISCOSITY;

ADHESIVENESS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG STABILITY; POVIDONE-IODINE; SPECTROPHOTOMETRY, ULTRAVIOLET; VAGINAL CREAMS, FOAMS, AND JELLIES; VISCOSITY;

EID: 37549017372     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701385782     Document Type: Article

References (19)

1. Acarturk, F., & Altug, N. (2001). In vitro and in vivo evaluation of a matrix controlled bromocriptine mesilate releasing vaginal ring. J. Pharm. Pharmacol., 53, 1721-1726.
2. Adham, I. S., & Gilbert, P. (1986). Effect of polyvinylpyrrolidone molecular weight upon the antimicrobial activity of povidone-iodine antiseptics. Int. J. Pharm., 34, 45-49.
3. Barabas, E. S., & Brittain, H. G. (1998). Povidone-iodine. In K. Florey (Ed.), Analytical profiles of drug substance and excipients (Volume 25, pp. 341-462). New York: Academic Press, Inc.
4. Block, J. H., Roche, E. B., Soine, T. O., & Wilson, C. O. (1986). Topical agents, Inorganic medicinal and pharmaceutical chemistry (pp. 301-348). Bombay: Varghese Publishing House.
5. Bouckaert, S., Temmerman, M., Voorspoels, J., Vankets, H., Remon, J. P., & Dhont, M. (1995). Preliminary efficacy study of a bioadhesive vaginal metronidazole tablet in the treatment of bacterial vaginosis. J. Pharm. Pharmacol., 47, 970-971.
6. British Pharmacopeia. (2000). The Stationary Office Limited, London.
7. Ceschel, G. C., Maffei, P., & Borgia, S. L. (2001). Development of a mucoadhesive dosage form for vaginal administration. Drug. Dev. Ind. Pharm., 27(6), 541-547.
8. Garg, S., Tambwekar, K. R., Vermani, K., Garg, A., Kaul, C. L., & Zaneveld, L. J. D. (2001). Compendium of pharmaceutical excipients for vaginal formulation. Pharm. Tech. Drug Delivery, 14-24.
9. Garg, S., Vermani, K., Kohli, G., Raghupathi, K., Tambwekar, K., Garg, A., Waller, D. P., & Zaneveld, L. J. D. (2002). Survey of vaginal formulations available on the Indian market: physicochemical characterization of selected products. Int. J. Pharma. Med., 16, 141-152.
10. Indian Pharmacopeia. (1996). The Controller of Publications, New Delhi.
11. Joglekar, A., Rhodes, C. T., & Danish, M. (1991). Preferences of women for use of intravaginal medications. Drug Dev. Ind. Pharm., 17(15), 2103-2113.
12. Ohshiro, S., Hokama, N., & Hobara, N. (1997). Determination of the povidone-iodine contents by high performance liquid chromatography. Jpn. J. Hosp. Pharm., 23(3), 202-206.
13. Owen, D. H., & Katz, D. F. (1999). A vaginal fluid simulant. Contraception, 59, 91-95.
14. Robinson, J. R., & Bologna, W. J. (1994). Vaginal and reproductive system treatments using a bioadhesive polymer. J. Contr. Release, 28, 87-94.
15. Shanbrom, E. (1996). Antiviral, spermicidal vaginal gel and foam containing low molecular weight povidone-iodine. U S Patent No. 5,545,401, Issued on August 13, 1996
16. Shelanski, H. A. (1956). Mixtures of polymeric N-Vinylpyrrolidone and halogens. U S Patent No. 2,739,922, Issued on March 27, 1956
17. United States Pharmacopeia 24 and National Formulary 19. (1999). United States Pharmacopeial Convention, Inc., Rockville.
18. Valenta, C., Kast, C. E., Harich, I., & Bernkop-Schnurch, A. (2001). Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J. Controlled Release, 77, 323-332.
19. Vermani, K., Garg, S., & Zaneveld, L. J. D. (2002). Assemblies for in vitro measurement of bioadhesive strength and retention characteristics in simulated vaginal environment. Drug Dev. Ind. Pharm., 28(9), 1133-1146.